VIZIDOR

This brand name is authorized in Estonia, Croatia, Lithuania, Poland, United Kingdom

Active ingredients

The drug VIZIDOR contains one active pharmaceutical ingredient (API):

1 Dorzolamide UNII QZO5366EW7 - DORZOLAMIDE HYDROCHLORIDE

Dorzolamide is a potent inhibitor of human carbonic anhydrase II. Following topical ocular administration, dorzolamide reduces elevated intra-ocular pressure, whether or not associated with glaucoma. Read about Dorzolamide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VIZIDOR Eye drops, solution	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01EC03	Dorzolamide	S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01EC Carbonic anhydrase inhibitors
Discover more medicines within S01EC03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1755480, 1755491, 1862445
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 393791
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1085363, 1085364
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100334034